
As the bidding for Corona Remedies Ltd's IPO wrapped up after a busy three-day window, investors are now eagerly waiting for the next big milestone, the allotment of shares. With the T+3 listing rule in place, the stock is expected to debut on the Indian exchanges three trading days after closure. This sets the most likely listing date at December 15, 2025, with the allotment expected on December 11, 2025.
The grey market has reacted enthusiastically following the robust subscription numbers. According to market trackers, Corona Remedies shares are trading at a premium of Rs 270 per share in the grey market today.
This puts the estimated listing price close to Rs 1,332 (Rs 1,062 issue price + Rs 270 GMP), suggesting a healthy 25% potential upside for those who receive allotment.
While GMP is not an official indicator, it often reflects market sentiment and investor appetite ahead of listing.
Investors can check whether they have secured shares through two official channels, the BSE website and the registrar, Bigshare Services Private Limited. Both platforms will update the allotment status once the finalisation is completed.
Once processed, the result will appear instantly on your screen, whether you are checking from a laptop, desktop, or mobile device.
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.